Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
出版年份 2017 全文链接
标题
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
作者
关键词
Mild cognitive impairment, Biomarkers, Tau, Phospho-tau, Amyloid-beta 42, Hippocampal volume, Prediction, Alzheimer’s dementia
出版物
Alzheimers Research & Therapy
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-10-10
DOI
10.1186/s13195-017-0301-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Magnetic Resonance Imaging Improves Cerebrospinal Fluid Biomarkers in the Early Detection of Alzheimer's Disease
- (2017) Miroslaw Brys et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design
- (2017) Ineke A. van Rossum et al. JOURNAL OF ALZHEIMERS DISEASE
- Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study
- (2016) Flora H. Duits et al. Alzheimers & Dementia
- Suspected non-Alzheimer disease pathophysiology — concept and controversy
- (2016) Clifford R. Jack et al. Nature Reviews Neurology
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
- (2015) Julien Dumurgier et al. Alzheimers Research & Therapy
- The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression
- (2015) Stefan J. Teipel et al. NeuroImage-Clinical
- Biomarker-based prediction of progression in MCI: comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau
- (2014) Bradford Dickerson Frontiers in Aging Neuroscience
- Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
- (2013) Kathryn A. Ellis et al. INTERNATIONAL PSYCHOGERIATRICS
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease
- (2013) Stefan J. Teipel et al. MEDICAL CLINICS OF NORTH AMERICA
- The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease
- (2013) Kaj Blennow et al. MEDICAL CLINICS OF NORTH AMERICA
- Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia
- (2013) Paula T. Trzepacz et al. NEUROBIOLOGY OF AGING
- Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
- (2013) S. J. B. Vos et al. NEUROLOGY
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
- (2013) A. Prestia et al. NEUROLOGY
- Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment
- (2013) Jonathan Young et al. NeuroImage-Clinical
- Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers
- (2013) Xiao Da et al. NeuroImage-Clinical
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
- (2012) Stephanie Vos et al. NEUROBIOLOGY OF AGING
- Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
- (2012) M. Wagner et al. NEUROLOGY
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging Initiative
- (2011) Jesus J. Gomar ARCHIVES OF GENERAL PSYCHIATRY
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Multimodal classification of Alzheimer's disease and mild cognitive impairment
- (2011) Daoqiang Zhang et al. NEUROIMAGE
- A Bayesian model of shape and appearance for subcortical brain segmentation
- (2011) Brian Patenaude et al. NEUROIMAGE
- Predicting MCI outcome with clinically available MRI and CSF biomarkers
- (2011) D. Heister et al. NEUROLOGY
- Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
- (2010) K.B. Walhovd et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
- (2010) A. M. Fjell et al. JOURNAL OF NEUROSCIENCE
- The clinical use of structural MRI in Alzheimer disease
- (2010) Giovanni B. Frisoni et al. Nature Reviews Neurology
- Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
- (2010) Christos Davatzikos et al. NEUROBIOLOGY OF AGING
- Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance
- (2010) Michael Ewers et al. NEUROBIOLOGY OF AGING
- Comparing predictors of conversion and decline in mild cognitive impairment
- (2010) S. M. Landau et al. NEUROLOGY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment
- (2009) Johannes Kornhuber et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change
- (2009) P. Vemuri et al. NEUROLOGY
- Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease
- (2009) B. Schmand et al. PSYCHOLOGICAL MEDICINE
- Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis
- (2008) A J Mitchell et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Development of Screening Guidelines and Clinical Criteria for Predementia Alzheimer’s Disease
- (2008) P.J. Visser et al. NEUROEPIDEMIOLOGY
- Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI☆
- (2008) C MISRA et al. NEUROIMAGE
- Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature
- (2008) Breno S. O. Diniz et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started